Article Versions Notes

Maddox AL, Brehove MS, Eliato KR, Saftics A, Romano E, Press MF, Mortimer J, Jones V, Schmolze D, Seewaldt VL, et al. Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer. Cancers. 2022; 14(11):2795. https://doi.org/10.3390/cancers14112795

Maddox, Adam L., Matthew S. Brehove, Kiarash R. Eliato, Andras Saftics, Eugenia Romano, Michael F. Press, Joanne Mortimer, Veronica Jones, Daniel Schmolze, Victoria L. Seewaldt, and et al. 2022. "Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer" Cancers 14, no. 11: 2795. https://doi.org/10.3390/cancers14112795

Maddox, A. L., Brehove, M. S., Eliato, K. R., Saftics, A., Romano, E., Press, M. F., Mortimer, J., Jones, V., Schmolze, D., Seewaldt, V. L., & Jovanovic-Talisman, T. (2022). Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer. Cancers, 14(11), 2795. https://doi.org/10.3390/cancers14112795